Practice Locations

UCHealth Pancreas and Biliary Multidisciplinary Clinic - Anschutz Medical Campus
1665 Aurora Ct 3rd Floor, Aurora, CO 80045

1-855-824-7262

S. Lindsey Davis, MD

Medical Oncology

Board Certified

S. Lindsey Davis

Clinical Interest for Patients

My clinical interests include the treatment of patients with cancers of the gastrointestinal tract and the involvement of patients in studies of new treatments for these cancers.

Credentials

Doctor of Medicine

Specialty

Internal Medicine, Medical Oncology

Scheduling Phone Number

720-848-0300

Gender

Female

Languages

English

Hospital Affiliation

University of Colorado Hospital

UCHealth Pancreas and Biliary Multidisciplinary Clinic - Anschutz Medical Campus

1665 Aurora Ct, 3rd Floor Aurora, CO 80045

Phone: 1-855-824-7262

Provider Information

  • Internal Medicine (2010)
  • Medical Oncology (2014)
  • Cancers

    Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)

Personal Interests
In my free time I enjoy running, hiking, skiing and traveling with my husband.


Associate Professor, Medicine-Medical Oncology

American Association for Cancer Research (AACR), Member American Society of Clinical Oncology (ASCO), Member

Research Interests for Patients

My research interests are primarily focused on the evaluation of new cancer treatments

Education and Training

Medical Schools

MD, University of Missouri-Columbia School of Medicine (2007)


Undergraduate Schools

BS, University of Arkansas (AR) (2003)


Internships

University of Colorado (2008)


Residency Program

University of Colorado (2011)


Fellowships

University of Colorado (2014)

Information for referring providers

Referral Contact Phone

720-848-0300

720-848-0300

Referral Contact Fax

720-848-0360

Referring Patients Link

Information for Referring and Transferring Patients

Clinical Interests for Referring Providers

My clinical interests include gastrointestinal cancers and developmental therapeutics.

Research Interest for Referring Providers

My research interests are primarily focused on the clinical development of novel targeted cancer therapies.